Finesse Solutions Announces CellWorld Shanghai 2016

Santa Clara, California (February 3, 2016) — Finesse Solutions announces the third CellWorld Shanghai Conference, an event specifically designed for innovators, visionaries and senior executives in bioprocessing.

 

The one-day conference will be held by invitation only at the InterContinental Shanghai Pudong, located at Pudong’s Lujiazui Finance and Trade Zone on June 21, 2016. The theme of the 2016 event is “The Future of Bioprocess in Asia.” Finesse intends this forum as platform for biopharma leaders to discuss the future of the biopharmaceutical industry in Asia and to share their experience in Asia.

 

Key speakers from Asia and the USA will present and discuss the changing landscape of the biopharmaceutical industry in Asia, industry trends, and regulatory requirements. Case studies in process development will be presented, and design and engineering companies will share their experiences in designing and building manufacturing facilities. Finesse will introduce innovative solutions for both upstream and downstream single-use bioprocessing with the use of novel measurement, automation and manufacturing execution (MES) systems.

 

“We have had overwhelming responses to our CellWorld conferences and we are excited to host this third CellWorld forum in Shanghai,” stated Barbara Paldus, CEO of Finesse Solutions. “We are extending this forum to other Asia biopharmaceutical leaders to explore innovation and technology, so that as a community, we can accelerate the adoption of new bioprocessing platforms and fully exploit highly intelligent tools that are rapidly becoming available through advances in electronics, software, and communications.”

 

About Finesse Solutions, Inc.

Finesse Solutions provides flexible hardware and software automation which allows for unmatched customizable bioprocessing. We are a research based Silicon Valley company who believe in empowering our clients with innovative single-use sensors, bioreactors, controllers and software. Our SmartParts are the foundation of Finesse solutions which use technologies from inside and outside the biopharmaceutical industry. In addition to our own products, we are the only supplier with integration expertise offering clients the independence to select any preferred supplier of key unit operations from upstream to downstream. Whether  a stand-alone, single-use bioreactor for research and development or a fully integrated SmartFactory for cGMP-compliant manufacturing, we have a bioprocess solution for our customers.

 

For more information, please visit us at finesse.com/cellworld/

 

Media: Barbara Paldus, 408 570 9012